Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Dermatology : EJD|April 10, 2013
Cheilitis, perioral dermatitis and contact allergyEvelyne Collet, Géraldine Jeudy, Sophie Dalac
Pediatric Dermatology|August 3, 2016
A Typical Vascular and Pigmentary Dermoscopic Pattern of Capillary Malformations in Capillary Malformation-Arteriovenous Malformation Syndrome: Report of Four CasesClaudine Gandon, Bertille Bonniaud, Evelyne Collet, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|August 25, 2025
Survival study of cervico-facial melanomas at 3 years without recurrence: impact of non-analysis of the sentinel lymph nodePauline Tschamber, Elise Boudousq, Leila Essid, et al.
Journal of the American Academy of Dermatology|July 13, 2011
Cutaneous B-cell lymphoblastic lymphoma in children: a rare diagnosisOlivia Boccara, Etty Laloum-Grynberg, Géraldine Jeudy, et al.
Journal for Immunotherapy of Cancer|September 11, 2020
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysisAlexandra Frazao, Louise Rethacker, Géraldine Jeudy, et al.
BMC Cancer|June 16, 2023
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocolLionnel Geoffrois, Alexandre Harlé, Nassim Sahki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomasDamien Sanogo, Romain Levard, Julie Cassecuel, et al.
Melanoma Research|March 30, 2023
Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literatureChloé Vuillamy, Jean-Philippe Arnault, Mathurin Fumery, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit SurveyCandice Lesage, Christine Longvert, Sorilla Prey, et al.
Pageof 3